SOURCE: Protectus Medical Devices, Inc.

January 20, 2010 09:00 ET

Protectus Medical Devices Signs National Distribution and Sales Broker Agreement With Synergistic Medical Network, LLC, Gaining Sales Force of 120+ Seasoned Professionals

MINNEAPOLIS, MN--(Marketwire - January 20, 2010) - Protectus Medical Devices, Inc. ("Protectus Medical Devices") (OTCBB: PTMD), a developer and marketer of innovative medical devices, announced today that the company has signed a nationwide distribution and sales broker agreement with Synergistic Medical Network, LLC to introduce its patented, self-sheathing, hypodermic safety syringe to physicians and hospitals throughout the United States. Synergistic Medical Network, LLC will serve as a national distributor and will utilize over 120 seasoned professionals as a sales force for Protectus Medical Devices. The innovative Protectus Safety Syringe is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades.

"We are excited about the opportunity to partner with Synergistic Medical Network, which brings us the infrastructure to market and distribute our safety syringe products nationwide," said Dr. John Salstrom, President and CEO of Protectus Medical Devices, Inc. "In conjunction with the agreement recently signed with our manufacturing partner, Moll Industries, Inc., this agreement is a key benchmark for Protectus Medical Devices that will allow the Company to bring our revolutionary safety syringe products to market."

Tom Newman, Managing Partner of Synergistic Medical Network, LLC (SMN), added, "At SMN, we seek to represent new medical device innovations that have a clear competitive advantage. Given the unique positioning and technology of Protectus Medical Devices and the fact that needlestick injuries continue to plague the healthcare workplace, we believe that we will successfully bring this unique safety syringe product to market and that our customer base will be very receptive to this major advance in safety syringe technology. We've built our business model specifically for rapid deployments of innovative products into the marketplace for situations just like this. Because our nationwide sales organization averages 20 plus years of experience, we can quickly introduce and distribute the Protectus product line to key physicians, hospital administrators, committees and other important decision makers."

The Protectus Safety Syringe is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike. It is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades. More information about Protectus Medical Devices may be found at the Company's corporate website at

About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)

Protectus Medical Devices, Inc. (PTMD, formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly, the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at

Forward-Looking Statements

This release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in Protectus Medical Devices, Inc.'s filings with the Securities and Exchange Commission.

Contact Information